Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Odyssey Therapeutics, Inc. | 62 908 | déclaré | 08 mai 2026 | tx 1+1 000 |
| LIGAND PHARMACEUTICALS INC | 6 606 | déclaré | 06 juin 2025 | tx 8+27 948 |
| Syros Pharmaceuticals, Inc. | 0 | déclaré | 18 nov. 2024 | tx 24+1 237 583−210 166 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 08 mai 2026 | PURCHASE | Odyssey Therapeutics, Inc. | 1 000 | 20.00 USD | 1er après silence |
| 06 juin 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1 209 | 0.00 USD | |
| 06 juin 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5 783 | 0.00 USD | deriv |
| 18 nov. 2024 | SALE | Syros Pharmaceuticals, Inc. | 137 803 | 0.21 USD | |
| 31 oct. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 5 624 | 2.09 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | — | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | 0.00 USD | deriv |
| 11 sept. 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 19 293 | 1.58 USD | |
| 12 sept. 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 45 344 | 1.68 USD | |
| 10 sept. 2024 | PURCHASE | Syros Pharmaceuticals, Inc. | 35 363 | 1.55 USD | |
| 14 juin 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1 252 | 0.00 USD | |
| 14 juin 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5 444 | 0.00 USD | deriv |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13 333 | — | |
| 01 avr. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4 732 | 5.12 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13 333 | 0.00 USD | deriv |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | — | |
| 01 nov. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6 301 | 2.22 USD | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | 0.00 USD | deriv |
| 09 juin 2023 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1 142 | 0.00 USD | |
| 09 juin 2023 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5 461 | 0.00 USD | deriv |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 03 avr. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 08 mai 2026.